ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
2022 · Annals of Oncology · 160 citations
https://doi.org/10.1016/j.annonc.2022.07.1941
A
Arlindo R. Ferreira
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
2.7K
Citations
23
h-index
37
i10-index
Arlindo R. Ferreira is an academic researcher from Universidade Católica Portuguesa. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies. The author has an h-index of 23, co-authored 105 publications.
ORCID: 0000-0002-1567-9322Papers by this author
worksBreast cancer surgery with augmented reality
2021 · The Breast · 67 citations
https://doi.org/10.1016/j.breast.2021.01.004
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
2017 · The Breast · 43 citations
https://doi.org/10.1016/j.breast.2017.11.004
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial
2019 · Breast Cancer Research and Treatment · 43 citations
https://doi.org/10.1007/s10549-019-05284-y
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study
2017 · Clinical Breast Cancer · 33 citations
https://doi.org/10.1016/j.clbc.2017.04.002
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
2020 · ESMO Open · 29 citations
https://doi.org/10.1136/esmoopen-2020-000842
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat